← Leaderboards
David Eisenberg
University Of California Los Angeles
$31,979,624
Attributed
$38,888,085
Total exposure
30
Grants
26
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$43,632,171 · 31
By mechanism
R01$14,919,268 · 5
P01$9,014,845 · 5
U24$7,757,977 · 1
RF1$6,119,813 · 2
U54$1,947,300 · 1
R56$1,872,967 · 2
Top collaborators
- Rakez Kayed5 shared
- Christopher D Keene5 shared
- Jeff A Kuret5 shared
- Andrew Bradbury4 shared
- Zygmunt S Derewenda4 shared
- Adam Godzik4 shared
- Thomas C. Terwilliger4 shared
- Geoffrey S. Waldo4 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Allan James Mackenzie-Graham$3,959,882
- Arthur P Arnold$16,949,215
- Jason P. Lerch$746,648
- Cassandra Eve Meyer$111,468
- Daniel Kaufman$8,790,517
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructureAlzheimer&AposBaseTau ProteinsCellsStructural BiologyProceduresCollaborationsGrantDesignResearch PersonnelComplexAmyloidCrystallizationVertebral ColumnS DiseaseAmyloidosisCommunitiesInhibitor/AntagonistMolecularBinding (Molecular Function)PeptidesBioinformatics
Grant awards (88)
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias$1,540,936
U24 · FY2025 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures$1,168,683
R01 · FY2025 · AG · contact PI
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias$1,547,815
U24 · FY2024 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures$1,192,535
R01 · FY2024 · AG · contact PI
TRD1: Dedicated sample preparation for MicroED$210,840
P41 · FY2024 · GM · contact PI
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias$1,554,543
U24 · FY2023 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures$1,192,535
R01 · FY2023 · AG · contact PI
TRD1: Dedicated sample preparation for MicroED$210,840
P41 · FY2023 · GM · contact PI
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias$1,544,885
U24 · FY2022 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures$1,068,405
R01 · FY2022 · AG · contact PI
TRD1: Dedicated sample preparation for MicroED$210,840
P41 · FY2022 · GM · contact PI
Interdisciplinary Research Network on Biologically Active Tau Aggregate Polymorphs from Alzheimer's Disease and Related Dementias$1,569,798
U24 · FY2021 · AG
Towards Treatment of Alzheimerâs Disease by Targeting Pathogenic Tau and Beta-Amyloid Structures$1,075,649
R56 · FY2021 · AG · contact PI
TRD1: Dedicated sample preparation for MicroED$210,840
P41 · FY2021 · GM · contact PI
TRD1: Dedicated sample preparation for MicroED$210,840
P41 · FY2020 · GM · contact PI
Development of inhibitors and diagnostics for amyloid diseases$1,950,000
RF1 · FY2019 · AG · contact PI
Identifying distinct tau polymorphs in Alzheimerâs disease and development of early diagnostics for aggregation of tau polymorphs$797,318
R56 · FY2018 · AG · contact PI
Structure and Inhibition of Amyloid in Alzheimer's Disease$389,888
RF1 · FY2018 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$315,700
R01 · FY2018 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$423,500
R01 · FY2017 · AG · contact PI
Development of Inhibitors for Systematic Amyloid Diseases$155,000
R01 · FY2017 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$107,800
R01 · FY2017 · AG · contact PI
Structure and Inhibition of Amyloid in Alzheimer's Disease$3,779,925
RF1 · FY2016 · AG · contact PI
Structural Biology of Amyloid Disease$361,742
R01 · FY2016 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$315,700
R01 · FY2016 · AG · contact PI
Enhancing crystallization with binding partners, symmetry and diversity$1,196,491
P01 · FY2015 · GM
Structural Biology of Amyloid Disease$350,890
R01 · FY2015 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$306,229
R01 · FY2015 · AG · contact PI
Proj 3: Enhancing crystallization by supplying natural binding partners$207,355
P01 · FY2015 · GM · contact PI
Enhancing crystallization with binding partners, symmetry and diversity$1,196,491
P01 · FY2014 · GM
Engineering of Proteins for Crystallography$406,614
R01 · FY2014 · GM
Structural Biology of Amyloid Disease$361,742
R01 · FY2014 · AG · contact PI
Development of inhibitors for systemic amyloid diseases$315,700
R01 · FY2014 · AG · contact PI
Proj 3: Enhancing crystallization by supplying natural binding partners$207,355
P01 · FY2014 · GM · contact PI
Project 4$103,947
P01 · FY2014 · NS · contact PI
Enhancing crystallization with binding partners, symmetry and diversity$1,154,613
P01 · FY2013 · GM
Engineering of Proteins for Crystallography$391,406
R01 · FY2013 · GM
Structural Biology of Amyloid Disease$341,846
R01 · FY2013 · AG · contact PI
Proj 3: Enhancing crystallization by supplying natural binding partners$200,098
P01 · FY2013 · GM · contact PI
Project 4$103,507
P01 · FY2013 · NS · contact PI
Enhancing crystallization with binding partners, symmetry and diversity$1,196,491
P01 · FY2012 · GM
Engineering of Proteins for Crystallography$399,900
R01 · FY2012 · GM
Structural Biology of Amyloid Disease$367,592
R01 · FY2012 · AG · contact PI
Proj 3: Enhancing crystallization by supplying natural binding partners$207,355
P01 · FY2012 · GM · contact PI
Project 4$113,123
P01 · FY2012 · NS · contact PI
A Core Database of Interacting Proteins$585,375
R01 · FY2011 · GM · contact PI
Engineering of Proteins for Crystallography$437,047
R01 · FY2011 · GM
Structural Biology of Amyloid Disease$388,699
R01 · FY2011 · AG · contact PI
Project 4$105,110
P01 · FY2011 · NS · contact PI
PRION PROTEIN (PRP) SEGMENTS AND PRION DISEASE$14,191
P41 · FY2011 · RR · contact PI
MYCOBACTERIUM TUBERCULOSIS RV3019C-RV3020C ESX COMPLEX$14,191
P41 · FY2011 · RR · contact PI
TRUNCATED ALPHAA AND ALPHAB CRYSTALLINS$14,191
P41 · FY2011 · RR · contact PI
?2-MICROGLOBULIN$14,191
P41 · FY2011 · RR · contact PI
A Core Database of Interacting Proteins$618,688
R01 · FY2010 · GM · contact PI
Structural Biology of TB Drug Targets$481,289
P01 · FY2010 · AI · contact PI
Structural Biology of Amyloid Disease$392,936
R01 · FY2010 · AG · contact PI
DESIGN AND STRUCTURE OF DRUGS AGAINST ALZHEIMER'S DISEASE$166,483
P50 · FY2010 · AG · contact PI
Project 4$108,724
P01 · FY2010 · NS · contact PI
MOLECULAR BASIS FOR INSULIN FIBRIL ASSEMBLY$24,807
P41 · FY2010 · RR · contact PI
STRUCTURE/ACTIVITY OF A MEMBER OF THE VAPBC FAMILY OF TOXIN ANTITOXIN SYSTEMS$24,807
P41 · FY2010 · RR · contact PI
MOLECULAR MECHANISMS FOR PROTEIN-ENCODED INHERITANCE$24,807
P41 · FY2010 · RR · contact PI
Structural Biology of TB Drug Targets$472,079
P01 · FY2009 · AI · contact PI
Structural Biology of Amyloid Disease$445,332
R01 · FY2009 · AG · contact PI
A Core Database of Interacting Proteins (DIP)$415,414
R01 · FY2009 · GM · contact PI
INSIGHTS INTO THE INTERACTION OF TWO CRITICAL PLAYERS IN ALZHEIMER DISEASE:$20,721
P41 · FY2009 · RR · contact PI
STRUCTURE/ACTIVITY OF A MEMBER OF THE VAPBC FAMILY OF TOXIN ANTITOXIN SYSTEMS$20,721
P41 · FY2009 · RR · contact PI
ATOMIC STRUCTURE OF THE CROSS-BETA SPINE OF ISLET AMYLOID POLYPEPTIDE (AMYLIN)$20,721
P41 · FY2009 · RR · contact PI
Subproject 1$542,456
U54 · FY2008 · GM · contact PI
Structural Biology of TB Drug Targets$459,949
P01 · FY2008 · AI · contact PI
Structural Biology of Amyloid Disease$432,690
R01 · FY2008 · AG · contact PI
A Core Database of Interacting Proteins (DIP)$403,544
R01 · FY2008 · GM · contact PI
Subproject 1$542,189
U54 · FY2007 · GM · contact PI
Structural Biology of TB Drug Targets$453,203
P01 · FY2007 · AI · contact PI
Structural Biology of Amyloid Disease$412,826
R01 · FY2007 · AG · contact PI
A Core Database of Interacting Proteins (DIP)$403,719
R01 · FY2007 · GM · contact PI
STRUCTURE OF AMYLOIDOGENIC PEPTIDES FROM MICROCRYSTAL SAMPLES$7,032
P41 · FY2007 · RR · contact PI
Structural Biology of TB Drug Targets$473,646
P01 · FY2006 · AI · contact PI
A Core Database of Interacting Proteins (DIP)$439,479
R01 · FY2006 · GM · contact PI
Subproject 1$286,476
U54 · FY2006 · GM · contact PI
STRUCTURE OF AMYLOIDOGENIC PEPTIDES FROM MICROCRYSTAL SAMPLES$6,682
P41 · FY2006 · RR · contact PI
Subproject 1$298,049
U54 · FY2005 · GM
Subproject 1$278,130
U54 · FY2005 · GM
CORE--STRUCTURAL BIOLOGY$167,178
P30 · FY2002 · CA
STRUCTURE AND RECOGNITION IN HEALTH RELATED PROTEINS$158,272
P01 · FY2002 · GM
CORE--STRUCTURAL BIOLOGY$167,178
P30 · FY2001 · CA
STRUCTURE AND RECOGNITION IN HEALTH RELATED PROTEINS$158,272
P01 · FY2001 · GM
STRUCTURE AND RECOGNITION IN HEALTH RELATED PROTEINS$257,475
P01 · FY2000 · GM
CORE--STRUCTURAL BIOLOGY$237,900
P30 · FY2000 · CA